NFE2L2 and neoplasm: In this regard, mutp53 activates glycolysis in cancer cells to promote cancer cell growth, another GOF for mutp53 [106], suggesting that unveiling the link between mutp53 and NRF2 oncogenic signaling may reveal additional druggable targets to manipulate the metabolic reprogramming and arrest tumor growth.